Furthermore, high expression of CEP55 indicated an unfavorable DFI for patients with KIRP, LIHC, LUAD, PAAD, SARC, and THCA, as well as poor PFI for those diagnosed with one of 14 cancers: ACC, ESCA, KICH, KIRC, KIRP, LGG, LIHC, LUAD, MESO, PAAD, PCPG, PRAD, SARC, and UVM. The gene discussed is CEP55; the disease is cancer.